0001209191-22-048195.txt : 20220831
0001209191-22-048195.hdr.sgml : 20220831
20220831200807
ACCESSION NUMBER: 0001209191-22-048195
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220812
FILED AS OF DATE: 20220831
DATE AS OF CHANGE: 20220831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVIN ARTHUR A
CENTRAL INDEX KEY: 0001181556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39321
FILM NUMBER: 221219262
MAIL ADDRESS:
STREET 1: 1896 RUTHERFORD ROAD
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avidity Biosciences, Inc.
CENTRAL INDEX KEY: 0001599901
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461336960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE
STREET 2: SUITE 125
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-401-7900
MAIL ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE
STREET 2: SUITE 125
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Avidity Biosciences LLC
DATE OF NAME CHANGE: 20161227
FORMER COMPANY:
FORMER CONFORMED NAME: Avidity NanoMedicines LLC
DATE OF NAME CHANGE: 20140211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-12
0
0001599901
Avidity Biosciences, Inc.
RNA
0001181556
LEVIN ARTHUR A
C/O AVIDITY BIOSCIENCES, INC.
10578 SCIENCE CENTER DRIVE, SUITE 125
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common Stock
2022-08-12
4
M
0
14003
0.53
A
15333
D
Common Stock
2022-08-12
4
S
0
14003
22.00
D
1330
D
Common Stock
2022-08-15
4
M
0
27740
0.53
A
29070
D
Common Stock
2022-08-15
4
M
0
34758
1.24
A
63828
D
Common Stock
2022-08-15
4
S
0
62498
22.1182
D
1330
D
Common Stock
2022-08-16
4
M
0
3499
1.24
A
4829
D
Common Stock
2022-08-16
4
S
0
3499
22.0798
D
1330
D
Common Stock
273872
I
By family trust
Stock Option (Right to Buy)
0.53
2022-08-12
4
M
0
14003
0.00
D
2027-08-28
Common Stock
14003
27740
D
Stock Option (Right to Buy)
0.53
2022-08-15
4
M
0
27740
0.00
D
2027-08-28
Common Stock
27740
0
D
Stock Option (Right to Buy)
1.24
2022-08-15
4
M
0
34758
0.00
D
2030-02-18
Common Stock
34758
131922
D
Stock Option (Right to Buy)
1.24
2022-08-16
4
M
0
3499
0.00
D
2030-02-18
Common Stock
3499
128423
D
The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.47.The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.30.The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On March 18, 2021, the Reporting Person filed a Form 4 reporting the total number of shares indirectly owned through a family trust. These indirect holdings were inadvertently omitted from the Reporting Person's subsequent reports on Form 4 filed on June 16, 2021, June 22, 2021, June 28, 2021 and November 22, 2021.
This option is exercisable as to vested and unvested shares. The option was granted on August 29, 2017 and 1/48th of the shares subject to the option vest monthly.
25% of the shares subject to the option vested on February 19, 2021, and 1/48th of the shares subject to the option will vest monthly thereafter.
On June 11 2020, the Reporting Person filed a Form 3 which inadvertently overreported the number of options under this option grant due to a typographical error. The aggregate number of options beneficially owned has been updated in this Form 4 to reflect the total number of options held by the Reporting Person following the transactions reported on this Form 4 and the Reporting Person's previously filed reports.
/s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact
2022-08-31